“This year, Pfizer has banked on selling 115 million pediatric doses to the U.S. government and expects to earn $36 billion in vaccine revenue. Congress is so in the pocket of Big Pharma that it’s against the law for our government to negotiate bulk pricing for drugs, meaning taxpayers must pay retail.”
